RE: Parsortix - FDA approval limitations2 Mar 2023 13:45
Perhaps a bidder is circling, who will be the one to update their webpage with a new name. No point in Angle plc updating the page.
At this share price, a bidder must be licking their lips. £100m + of researsch spent, commercial relations developed, FDA clearance, which they can buy for £63m.